While still in the experimental stages, a new imaging system holds promise as a cheaper alternative to MRIs. Molecular breast imaging (MBI), utilizes an injection of tracer particles that are only picked up by cells that are more active than normal, such as cancer cells. A camera then picks up the gamma rays emitted by the tracer particles.
